From Scrubs to Coats: Zenir Introduces New White Lab Coat Collection for Healthcare Professionals
Zenir, the trusted name in premium medical scrubs, has officially expanded its product lineup with the launch of its first white lab coats available now for both men and women in short and long lengths.
Torrance, California, United States, June 14, 2025 -- Zenir, the trusted name in premium medical scrubs, has officially expanded its product lineup with the launch of its first white lab coats available now for both men and women in short and long lengths. Known for combining functional innovation with elevated style, Zenir continues to raise the standard for medical workwear with this new release.
The newly launched white lab coats faithfully embody Zenir's philosophy of comfort, practicality, and refined style. The short-length lab coat is engineered with a three-dimensional pattern that naturally facilitates shoulder and arm movement ideal for dynamic, active roles while the long lab coat features a subtly cinched waistline and matte hidden snap buttons to deliver a sleek, professional silhouette in clinical settings. Meticulously designed storage details, such as a dedicated pen holder in the chest pocket and an inner pocket for smartphones, balance functionality with clean design. Optimized for fast-paced healthcare environments, this collection not only meets workplace requirements but also offers a range of fits and style options to suit every body shape and individual preference.
Already recognized for its high-performance scrubs, Zenir is a brand trusted by thousands in the healthcare industry and has sold more than 3 million units globally. The brand has earned its reputation for premium-quality scrubs that are breathable, durable, wrinkle-resistant, and moisture-wicking, now extended to its latest line of white lab coats.
As Zenir continues to grow its presence beyond Korea, this expansion into white lab coats marks a milestone in Zenir's commitment to offering a complete spectrum of medical workwear solutions. With thoughtfully tailored cuts, sustainable production using GRS-certified recycled fibers, and a design-first approach, Zenir's new white lab coats are built for professionals who expect more from their daily uniform.
For more details, visit shopzenir.com.
Contact Info:
Name: Jiho Jang
Email: Send Email
Organization: Zenir
Website: https://www.shopzenir.com
Release ID: 89162171
In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TechCrunch
21 minutes ago
- TechCrunch
Google reportedly plans to cut ties with Scale AI
In Brief Meta's big investment in Scale AI may be giving some of the startup's customers pause. Reuters reports that Google had planned to pay Scale $200 million this year but is now having conversations with its competitors and planning to cut ties with the startup. Microsoft is also reportedly looking to pull back, and OpenAI supposedly made a similar decision months ago, although its CFO said the company will continue working with Scale as one of many vendors. Scale's customers include self-driving car companies and the U.S. government, but Reuters says its biggest clients are generative AI companies seeking access to workers with specialized knowledge that they can use to annotate data for training models. A Scale spokesperson declined to comment on the company's relationship with Google, but he told TechCrunch that Scale's business remains strong, and that it will continue to operate as an independent company that safeguards its customers' data. Earlier reports suggest that Meta invested $14.3 billion in Scale for a 49% stake in the company, with Scale CEO Alexandr Wang joining Meta to lead the company's efforts to develop 'superintelligence.'
CNN
24 minutes ago
- CNN
Anne Wojcicki's nonprofit wins bid to acquire genetic testing company 23andMe
A nonprofit led by Anne Wojcicki, the co-founder and former chief executive of 23andMe, won a bid to acquire the genetic testing company following its bankruptcy filing in March. Wojcicki's California-based nonprofit, TTAM Research Institute, will purchase 23andMe for $305 million, according to a news release on Friday. It's the final twist in the bidding war between TTAM and Regeneron Pharmaceuticals, which announced on May 19 that it would buy most of 23andMe's assets for $256 million. The Wall Street Journal reported that New York-based Regeneron cited 'its assessment of 23andMe's remaining value' for not submitting a higher bid. 23andMe and Regeneron did not respond to CNN's request for comment. Wojcicki stepped down from 23andMe on March 24, when the company filed for Chapter 11 bankruptcy. 23andMe's struggles drew attention in September 2024 when all seven of the company's independent directors resigned en masse, citing frustration with Wojcicki's 'strategic direction' and efforts to take the company private. In November 2024, 23andMe cut about 40% of its workforce, or roughly 200 employees, and discontinued developments of its therapies in a restructuring effort. 23andMe, which at one point was valued at $6 billion, has collected genetic data from 15 million customers through at-home DNA testing kits that used saliva samples. The testing kits offered 'personalized genetic insights' that could flag potential health risks. But 23andMe struggled to convert one-time buyers into subscribers. The company's bankruptcy filing sparked concern about data privacy, as customers worried their genetic information would be sold to a third party. Twenty-seven states and the District of Columbia filed a lawsuit on Monday against 23andMe to block the sale of genetic data without customer consent. Interested companies could use 23andMe's data to personalize their products or advertising. Genetics can be linked to food preferences, for instance. Genetic data could also be used when developing personalized medicine, Gideon Nave, an associate professor of marketing at the University of Pennsylvania's Wharton School, told CNN in March. There aren't many restrictions in place to prevent genetic discrimination, although the Genetic Information Nondiscrimination Act prevents gene information from being used for discrimination in health insurance coverage or employment. According to the news release, TTAM said that it will comply with 23andMe's privacy policies and honor existing policies regarding customer data rights, such as deleting accounts and opting out of research. 'I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome. We believe it is critical that individuals are empowered to have choice and transparency with respect to their genetic data and have the opportunity to continue to learn about their ancestry and health risks as they wish,' Wojcicki said in a news release. TTAM, an acronym for the first letters of 23andMe, will acquire 'substantially all' of 23andMe's assets, including its personal genome service, research services and Lemonaid Health, a telehealth program acquired by the company in 2021. The deal still needs to be approved by the US Bankruptcy Court for the Eastern District of Missouri. A hearing is scheduled for June 17, according to the release. CNN's Lisa Eadicicco contributed to this report.
Yahoo
24 minutes ago
- Yahoo
Sea turtle rehab center closes at Gumbo Limbo
BOCA RATON — The Sea Turtle Rehabilitation Center at the Gumbo Limbo Nature Center has been closed, the nonprofit operating the turtle hospital announced Friday. The Coastal Stewards said in a news release it was closing the center for financial reasons. 'Like many environmental nonprofits, The Coastal Stewards has faced increasing difficulty securing consistent and sustainable funding,' said Shivani Gupta, Board of Trustee member at The Coastal Stewards, in a prepared statement. 'This difficult decision allows us to reallocate resources and focus on our long-standing commitment to marine conservation education and empowering the next generation of ocean advocates.' The gift shop at the center also has been closed, Coastal Stewards said. The 13 sea turtle patients currently being treated at Gumbo Limbo are receiving veterinary care and will be transferred to other licensed sea turtle rehabilitation facilities when they become available, the nonprofit said, adding that it is working with the Florida Fish and Wildlife Conservation Commission during this process. The three resident sea turtles in tanks at the Gumbo Limbo center remain on view for the public, Coastal Stewards said. The center is operated by the city of Boca Raton. In a statement on its website announcing the closure of the rehab facility, the city said the center "remains fully open and active. The Center will continue its conservation and education efforts, including its sea turtle nesting and hatchling programs, youth camps, community education and other popular visitor attractions." The city said it is "open to exploring partnerships with other qualified nonprofit organizations that may be interested in continuing sea turtle rehabilitation on-site and will determine the best use of the gift shop space." This article originally appeared on Palm Beach Post: Sea turtle rehab center at Boca's Gumbo Limbo closes
